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Abstract
Background: The transcriptional response to many widely used drugs and its modulation by genetic variability is
poorly understood. Here we present an analysis of RNAseq profiles from heart tissue of 18 inbred mouse strains
treated with the β-blocker atenolol (ATE) and the β-agonist isoproterenol (ISO).
Results: Differential expression analyses revealed a large set of genes responding to ISO (n = 1770 at FDR = 0.0001)
and a comparatively small one responding to ATE (n = 23 at FDR = 0.0001). At a less stringent definition of
differential expression, the transcriptional responses to these two antagonistic drugs are reciprocal for many genes,
with an overall anti-correlation of r = −0.3. This trend is also observed at the level of most individual strains even
though the power to detect differential expression is significantly reduced. The inversely expressed gene sets are
enriched with genes annotated for heart-related functions. Modular analysis revealed gene sets that exhibit
coherent transcription profiles across some strains and/or treatments. Correlations between these modules and
a broad spectrum of cardiovascular traits are stronger than expected by chance. This provides evidence for the
overall importance of transcriptional regulation for these organismal responses and explicits links between
co-expressed genes and the traits they are associated with. Gene set enrichment analysis of differentially
expressed groups of genes pointed to pathways related to heart development and functionality.
Conclusions: Our study provides new insights into the transcriptional response of the heart to perturbations of
the β-adrenergic system, implicating several new genes that had not been associated to this system previously.
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Background
The effects of many drugs are mediated by transcrip-
tional changes. Variability in drug response can be due
to different environment as well as distinct genetic
and epigenetic backgrounds. Yet, how and to what ex-
tent these variables affect drug response is usually
poorly understood (see [1–5] for reviews of recent ad-
vances [6]).
The β-adrenergic system exerts a tight physiological
control on cardiac performance and contractility. How-
ever, when placed under conditions of exacerbated and
sustained stimulation triggered by persisting cardiac
insult or hypertension, its maladaptive response causes
cardiac hypertrophy that, if not treated adequately, will
ultimately lead to heart failure [7]. A range of β-blocking
drugs, such as the β1-selective antagonist atenolol
(ATE), have been developed to counter these effects. In
the clinic, they are routinely prescribed for the manage-
ment of heart failure, myocardial infarction, angina,
atrial fibrillation and hypertension [8]. Conversely, long-
term exposure of cellular or animal models to β-agonists
such as the non-selective activator isoproterenol (ISO)
can be used in the laboratory to mimic and study cardiac
hypertrophy, independently of hypertension [9].
Owing to the broad diversity and heterogeneity of
clinical presentations and interactions with environmen-
tal factors, the genetic etiologies of heart failure and
response variability to β-blocking therapy remain poorly
understood [10]. This complexity is reflected by the very
small number of successful genome-wide association
studies (GWASs) for heart failure and related pheno-
types reported so far, despite meta-analyzing up to tens
of thousands of patients [11–16].
Genetic reference populations (GRPs) such as those
composed of panels of inbred mouse strains provide at-
tractive alternatives to study complex traits. Not only
are such panels genetically stable and environmentally
controllable, but they also allow for longitudinal data
acquisition, replication in multiple individuals or across
laboratories and facilitated access to organs and tissues.
Taking advantage of these principles, we recently inves-
tigated the organismal response of a population of 22
inbred mouse strains to ATE and ISO [17]. Our phenotypic
dataset consisted of 27 highly heritable cardiovascular-
related traits, each measured across the various strains and
treatment conditions. Subsequently, we screened for
genetic variants significantly correlated with these traits
by genome-wide association mapping [18]. The most
genome-wide significant hits included three candidate
loci related to cardiac and body weight, three loci for
electrocardiographic (ECG) values, two loci for the
susceptibility of atrial weight to ISO, four loci for the
susceptibility of systolic blood pressure to perturbations
of the β-adrenergic system, and one locus for the re-
sponsiveness of the ECG QTc interval. These and about
100 additional marginally significant loci for cardiac-
related traits were enriched in genes expressed in the
heart.
In the present work, we have analyzed the cardiac ex-
pression patterns of 160 representative individuals of the
same population of mice by RNA sequencing (RNAseq),
considering 18 of the initial 22 strains. Our goal was to
identify the transcriptional changes induced by ATE and
ISO, study their modulation by the genetic background,
and investigate their relation with the phenotypic traits
measured earlier. We first examined the overall tran-
scriptional response, pooling the data of control animals
as well as those of mice treated with ISO and ATE,
respectively. We analyzed the distributions of cross-
sample correlations and performed principal component
as well as clustering analyses. We then identified sets of
genes that were either induced or repressed by each
drug across all or most strains. Our key observation is
that there was a strong enrichment for genes showing
reciprocal responses to ATE and ISO, while not a single
gene was significantly induced or repressed by both
compounds. A finer modular analysis revealed transcrip-
tion modules representing gene sets that exhibited
coherent transcription profiles for some strains and/or
treatments. Globally, module gene expression correlates
with the phenotypic traits measured earlier [9]. Gene set
enrichment analysis of differentially expressed groups of
genes revealed pathways related to heart development
and functionality. Our study provides a rich resource for
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the better understanding of how pharmacological pertur-
bations of the β-adrenergic system affect the cardiac
transcriptome and how these changes impact on heart-
related traits within different mouse strains.
Results
On average, 20 million of sequencing reads were obtained
for each sample (Additional file 1: Figure S1). After filter-
ing out 2896 genes with inconsistent evidence of expres-
sion (see Methods), read counts of the remaining 16397
genes were normalized with the trimmed mean of M-
values (TMM) method [19]. We took a first global look at
these data by computing all pairwise Pearson correlations
Css’ between samples and across genes. We assigned these
correlations into four classes (Additional file 1: Figure S2):
(1) 158 correlations between biological replicates (i.e. same
strain and same treatment), (2) 474 correlations between
samples of the same strains assessed under distinct treat-
ments, (3) 4029 correlations between samples of different
strains assessed under the same treatments and (4) 8059
correlations between samples of different strains assessed
under distinct treatments. All cross correlations are rela-
tively high (Cmin = 0.929; Additional file 1: Figure S3),
indicating that the expression of the vast majority of
genes is neither affected significantly by treatment nor
by genetic background. Nevertheless, the highest corre-
lations are seen, as expected, between biological repli-
cates with C1 = 0.970 ± 0.003 (mean ± SD), whereas the
lowest correlations occur between unrelated samples
(C4 = 0.950 ± 0.005). Intra-strain (C2 = 0.965 ± 0.005) and
intra-treatment correlations (C3 = 0.955 ± 0.005) are dis-
tributed in between, yet the former are significantly higher
than the latter (t2,3 ≈ 49, p2,3 < 3.9 × 10
−211). This suggests
that, overall, genetic differences between the various
strains have a stronger impact on changes in gene expres-
sion than pharmacological treatments.
We next performed a cluster analysis of the inter-
sample correlation matrix, reordering it in such a way
that similar samples tend to be close to each other and
using 1-Css’ as similarity measure between the samples
(Additional file 1: Figure S4). This clustering reflects the
properties of the four categories of correlations de-
scribed above: almost all samples clustered first by bio-
logical replicates and then predominantly by strain,
rather than by treatment. Given the high intra-replicate
correlations, we computed a new expression matrix
averaging across replicates. This matrix had 54 condi-
tions (1 control, 1 ISO and 1 ATE for each of the 18
strains). Clustering the corresponding cross-condition
matrix revealed that conditions were grouped predomin-
antly by strain, with the exception of few related strains
(C57BL/6J and C57BLKS/J as well as BALB/cByJ and
BALB/cJ) that clustered together under ISO (Additional
file 1: Figures S5-S8).
As a second means to reveal the global structure of
the expression data, we performed principal component
analysis (PCA). Projection of the data onto the first two
principal components reflected the aforementioned cor-
relation structure, placing biological replicates, and to a
lesser extent samples from the same strain, close to each
other (Fig. 1). The PCA further showed that ISO
samples tend to better segregate from the untreated
controls (CTR) of the same strains than the ATE
samples, revealing a stronger transcriptional response to
ISO than ATE.
We next focused on gene expression changes induced
by ISO or ATE. For this, we used the edgeR software
[20], delivering the average fold change (FC) and a
significance value pFC for the differential expression of
each gene under the two drugs across all strains. At the
FDR level of 0.0001, there are 1770 differentially
expressed (DE) genes (958 up-regulated, 812 down-
regulated) for the ISO-CTR comparison and 23 DE
genes (12 up-regulated, 11 down-regulated) for the
ATE-CTR one, in a total of 15966 genes surviving low-
count filtering in both comparisons. The sizable difference
in the number of DE genes across the two comparisons
corroborates the higher transcriptional impact of ISO than
ATE on the β-adrenergic system, indicated already by our
PCA analysis. This observation holds well at various
thresholds of significance (Table 1).
The ATE treatment elicits FCs by a factor of at most
four but lower than two for the vast majority of genes,
while for ISO we observed a few genes with higher mag-
nitudes. These differences are even more pronounced in
terms of significance, with all but one gene with a pFC >
10−10 for ATE, while a sizable number of them had
much smaller p-values for ISO (Additional file 1: Figure
S9a-b). As a consequence we found that a signed signifi-
cance value, that we termed Differential Expression
Index (DEI), was the most useful single measure to
characterize DE across a range of significance values.
The DEI is defined as the product of the sign of the log
FC and the log of its p-value:
DEI ¼ sign log FCð Þ½ ⋅ − log10 pFCð Þ
 
It is strongly correlated to the average log FC itself
(r ≈ 0.609 ± 0.010, p < 2.2 × 10−308 for ISO and r ≈ 0.608
± 0.022, p < 2.2 × 10−308 for ATE, as computed at a
confidence level of 95 %) but it can only be sizable if the
FC is consistent across biological replicates (i.e. if there
is statistical evidence for differential expression). This is
expected as high FC reflects a substantial difference in
read counts, which will lead to a small p-value as long as
the FC is consistent across biological replicates (i.e. if
there is statistical evidence for differential expression).
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To compare differential expression under the two treat-
ments, we plotted the DEI values for ISO against those for
ATE (Fig. 2, Additional file 1: Figure S9c-d). These DEIs
are anti-correlated (r ≈ −0.391 ± 0.013, p < 2.2 10−308),
indicating that at least part of the transcriptional re-
sponses triggered by ISO and ATE is reciprocal. At a very
stringent FDR of 0.0001 for Benjamini-Hochberg [21]
corrected p-values, 10 genes are induced by ATE but
repressed by ISO (we refer to these genes as to “counter-
expressed” genes CEISO
ATE), whereas 10 genes are induced
by ISO but repressed by ATE (CEISOATE), as highlighted in
Fig. 2. The numbers of CEISO
ATE and CEISOATE genes as a func-
tion of different FDR thresholds are reported in Table 2.
Strikingly, there is not a single “co-expressed” gene that is,
up to a FDR threshold of 0.01, induced or repressed under
both treatments (Fig. 2, Additional file 1: Figure S9). It is
important to note that the observed anti-correlation
between DEI(ATE-CTR) and DEI(ISO-CTR) is strongest
for the genes whose DEIs are both significant, but that the
trend persists even when considering larger gene sets
where either or both DEI are not significant.
We verified that the human orthologs of the 20 CE
genes are expressed in the heart (according to the MGI
database [22], available at http://www.informatics.jax.org/
). Most of these genes appear to be relevant in the context
of prolonged cardiac excitation or blockade. Specifically,
Lims1 is required for normal development of cranial and
cardiac neural crest-derived structures [23] and mice
double knockout for Lims1 and 2 develop dilated cardio-
myopathy and die of heart failure within 4 weeks [24].
Etv5 codes for a transcription factor involved in skeletal
muscle acetylcholine-gated channel clustering at neuro-
muscular junctions; it belongs to the most abundant
Ets transcripts in the early embryonic mouse heart [25]
and gene targeting in zebrafish suggested a role in embry-
onic cardiac patterning [26]. Myom2 codes for myomesin,
Fig. 1 Principal component analysis of the TMM-normalized reads in the 160 samples. The loadings of the first two principal components are
plotted against each other for each sample. The type of treatment is indicated by the shape of the markers (circles for CTR, triangles for ATE and
squares for ISO), while the filling of the markers refers to the strains (see legend on the right). Biological replicates (same shape and filling) tend
to cluster together. For any given strain the markers corresponding to CTR and ATE are usually not far apart, while those for ISO tend to be more
distal with smaller loadings on both principal components. This effect is visualized by the ellipsoids, whose centers and major axes reflect the first
two moments of the respective distributions (see legend on top)
Table 1 Differentially expressed (DE) genes
Gene response FDR < 5×10−2 FDR < 10−2 FDR < 10−3 FDR < 10−4
up-regulated by ISO (DEISOCTR) 2501 1826 1289 958
down-regulated by ISO (DEISO
CTR) 2402 1669 1132 812
total for ISO 4903 3495 2421 1770
up-regulated by ATE (DEATECTR) 41 28 18 12
down-regulated by ATE (DEATE
CTR) 42 24 15 11
total for ATE 83 52 33 23
Number of DE genes obtained at four different FDR thresholds for samples pooled by treatment
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the major component of myofibrillar M bands in verte-
brates; human MYOM2 mutations are associated with
hypertrophic cardiomyopathy [27], while overexpression
of EH-myomesin, the predominant MYOM2 isoform in
the embryonic heart, has been suggested as a biomarker
of dilated cardiomyopathy [28]. Synpo2l encodes a cyto-
skeletal, heart-enriched, actin-associated protein; knock-
down in zebrafish causes aberrant cardiac and skeletal
muscle development and function [29], whereas human
variants are associated with atrial fibrillation [30]. Ryr2 en-
codes a ryanodine receptor found in the sarcoplasmic
reticulum of cardiac muscle cells. This receptor is a
component of a calcium channel that supplies calcium to
cardiac muscle. Human RYR2 mutations are associated
with stress-induced polymorphic ventricular tachycardia
[31–36] and arrhythmogenic right ventricular dysplasia
[37]. Acta2 codes for a skeletal muscle alpha actin. Defects
in this gene lead to a diversity of vascular diseases, includ-
ing aortic aneurysm [38], premature onset of coronary
artery disease and premature ischemic strokes [39].
Fitm2 codes for an endoplasmic reticulum protein in-
volved in fat storage and homeostasis of cellular triglycer-
ides; in skeletal muscle, it participates to the regulation of
energy metabolism [40]. Phkg1 codes for the broadly
Fig. 2 Uncorrected differential expression index (DEI) of the ISO-CTR comparison plotted against that of ATE-CTR. Each dot represents one of the
15966 genes for which it was possible to assign DEI values in both treatment groups. The color of the dots reflects the local gene density (the
lighter the denser). The DEIs are anti-correlated (r = −0.3). The dashed lines at DEI = ±4.96 for ISO-CTR comparison and DEI = ±7.13 for ATE-CTR
correspond to a (corrected) FDR of 0.0001. Genes passing both thresholds are observed in the upper-left and lower-right quadrants only, defining
two sets of counter-expressed (CE) genes: CEISO
ATE genes (shown in purple) and CEISOATE (in green); the corresponding gene names are shown in the
respective lists (10 genes each). The ordinal number preceding the CE genes reflects the gene rank according to the linear combination of the
two DEI indexes. Strain-specific versions of this plot can be found in Additional file 1: Figures S20-S21
Table 2 Counter-expressed (CE) and co-expressed (CoE) genes
Gene response FDR < 5×10−2 FDR < 10−2 FDR < 10−3 FDR < 10−4
up-regulated by ISO but down-regulated by ATE (CEISOATE) 34 22 14 10
down-regulated by ISO but up-regulated by ATE (CEISO
ATE) 34 24 15 10
total for counter-expressed (CE) 68 46 29 20
up-regulated by ISO and ATE (CoEISO ATE) 2 0 0 0
down-regulated by ISO and ATE (CoEISO ATE) 0 0 0 0
total for co-expressed (CoE) 2 0 0 0
The number of counter-expressed (CE) and co-expressed (CoE) genes obtained for samples pooled by treatment is presented at four different FDR thresholds. CE
genes survive stringent FDR thresholds while the significance of the few co-expressed genes is much less robust
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expressed phosphorylase kinase gamma, an enzymatic
mediator of the neurohormonal regulation of glycogen
breakdown; it is further involved in cellular pathways
relevant to β-adrenergic stimulation such as c-AMP-
dependent PKA signaling and Ca2+ signaling, and is
high in muscle. Camta1 codes for the calmodulin bind-
ing transcription activator 1, an apparent regulator of
Ca2+-dependent adult stem cell commitment to myo-
cardial lineage [41]. Finally, Polr1e codes for a compo-
nent of the RNA polymerase I complex, that is active in
the transcription of ribosomal RNAs and has been in-
volved in the response to mechanical loading in a
mouse model of muscle hypertrophy [42].
Reactivation of the fetal transcriptional program is a
well-known hallmark feature of cardiac hypertrophy [9].
Therefore, it was expected that among the genes in-
duced by ISO, a subset would relate to early cardiac de-
velopment. What is interesting here is that even in the
absence of heart failure, at least some of these genes can
be down-regulated by ATE, suggesting that up to some
extent, β-adrenergic blockade may not only block but
also reverse the process of cardiac remodeling triggered
by cardiac insult.
In line with the above, Gene Ontology (GO) analyses of
the CE gene sets with DAVID [43] indicate that CEISO
ATE set
is enriched for genes related to “calmodulin binding”,
whereas CEISOATE genes significantly overlap with the more
general classes of “calcium signalling” and “contractile
fiber”. Analysis of the combined set further points to
“muscle contraction” and related terms, which are all
essential features of cardiac function (Additional file 2:
Table S1). Owing to the small number of genes taken into
consideration, these enrichments are not highly significant.
Relaxing the FDR threshold gives rise to larger gene
sets but these are enriched for many Gene Ontologies
that mostly refer to very general categories (data not
shown). We therefore decided to investigate further the
sets of CE genes using GOSeq [44] and scanning over
several thresholds. Retaining only annotation terms that
were enriched across a range of threshold (see Methods
and Additional file 3) yielded many terms specific of
heart-related features. This is particularly the case for
the subset of CEISOATE genes (Additional file 1: Figures
S10-S17), that appears strongly associated to cardiac
muscle action potential, contraction and conduction, as
well as for the combined list of CEISOATE and CEISO
ATE genes
(data not shown). The subset of CEISO
ATE genes is overrep-
resented in more general cellular processes of prolifera-
tion and division, although several cellular component
(CC) categories include heart-related terms, such as M-
band, contractile fiber part and myofibril.
When pooling the data across all strains to compare
treated against control samples we achieved excellent
power to detect DE genes. In contrast, using edgeR to
compute a strain-specific differential expression index
DEI(s) by comparing just the three ISO or ATE replicates
of a given strain s against the corresponding CTR samples,
power was significantly reduced. This is reflected by the
much lower count of DE genes detected in each strain
when compared to the figures discussed above (compare
Table 1 with Additional file 2: Table S2). In particular, for
many strains we could only detect DE genes under ATE
treatment at a relaxed FDR and none at all in strains
BALB/cByJ, BALB/cJ, I/LnJ and LP/J, even at a FDR of
0.05. At the level of individual strains, NODShiLt/J mice
are by far the strongest transcriptional responders to ISO,
while C57BL6/J animals are the most responsive to ATE
(Additional file 2: Table S2 and Additional file 1: Figures
S18-S19).
Decreased power is the likely reason why for most
strains we did not observe any significant anti-correlation
between the DEI(s) values for ISO and ATE (Additional
file 1: Figures S20-S21). We therefore searched for a more
sensitive measure of counter-expression by restricting our
analyses to the ISO-responsive genes (since ISO affects













where z(…) indicates a z-score normalization with re-
spect to G(t) which is the set of genes for which
|DEIISO-CTR| = −log10(p
ISO-CTR) > t and |G(t)| is its size.
So CEI(t) is nothing more than the correlation between
two DEIs after removing non-significant genes (under
ISO). Using a threshold t = 4 we found that 16 out of 18
strains obtained a negative CEI and that this trend
changes only at a very low level of significance for DE
genes (Additional file 1: Figures S22-S25). Nevertheless,
although this confirms that anti-correlated expression
between the two treatments is present in the large ma-
jority of strains, the individual signals are quite weak
(Additional file 1: Figures S22-S25).
To evaluate the extent by which drug-induced expres-
sion changes are strain-specific and whether strain specifi-
city differs between treatments, we introduced a Strain-
Specificity Index (SSI). This index is computed from the
strain-specific DEI(s). It is defined by analogy with the





with xs ¼ jDEIðsÞj
maxNss¼1jDEIðsÞj
The SSI of a given gene and treatment vanishes if its
DEI values are identical across all strains and it is small
if they are similar. In contrast, the SSI equals one if the
gene is differentially expressed in a single strain and is
close to one if its expression is specific to relatively few
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strains. Intermediate values indicate partial strain specifi-
city. Note that the absolute value of the DEI is used, so
only the significance but not the direction of the differ-
ential expression is relevant here.
Plotting the SSI values of ATE-CTR versus those of
ISO-CTR (Fig. 3) revealed that most genes exhibit
relatively high strain-specificity (the mean ± SD of the
respective distributions are 0.71 ± 0.31 for ISO and 0.72
± 0.32 for ATE, respectively). Also, we observed a very
mild global correlation (r ≈ 0.078, p < 9.0 × 10−21), so for
the vast majority of genes any SSI value in one treatment
is uninformative of its value in the other. This is not
unexpected, since most genes are not affected signifi-
cantly by either treatment. We therefore asked whether
CE genes behave differently. At a stringent FDR of
0.0001, the respective correlation coefficients (CEISO
ATE:
r ≈ 0.76, p < 0.01; CEISOATE: r ≈ 0.51, p < 0.13) are much
higher, but not very significant. Yet, genes of both CEISO
ATE
and CEISOATE sets tend to have a significantly lower SSI(ISO)
(t ≈ 5.4, p < 0.0004 for CEISO
ATE and t ≈ 9.6, p < 5.1 × 10−6 for
CEISOATE) and SSI(ATE) (t ≈ 7.6, p < 3.2 × 10
−5 for CEISO
ATE
and t ≈ 8.2, p < 1.7 × 10−5 for CEISOATE). The combined set of
CEISO
ATE and CEISOATE genes shows an intermediate correl-
ation (r ≈ 0.60, p < 0.0047). The shift of the SSI(ISO)
distribution towards lower values (i.e. less specificity) is
reflected by a t-statistic t ≈ 8.9, p < 3.3 × 10−8 while that of
the SSI(ATE) has t ≈ 10.4, p < 2.5 × 10−9. These correla-
tions refer to a definition of DE genes at a FDR < 0.0001.
They hold at less stringent thresholds as well (data not
shown). Taken together, these results show that the CE
genes are significantly less strain-specific than the other
genes.
In the paragraphs above, we saw that the transcrip-
tional response of individual genes under specific envir-
onmental conditions and/or genetic backgrounds is
often quite weak and can be difficult to detect due to
the overall noise when using only a few biological repli-
cates. The power to detect strain-specific regulation can
be increased in principle by integrating signals from
multiple genes which are expressed differentially only
across subsets of strains and a number of methods have
been proposed for the unsupervised identification of
such subsets. Here we used the Iterative Signature
Algorithm (ISA) [46, 47], which identifies transcription
modules consisting of subsets of genes that are either
coherently induced or repressed over some, but usually
not all samples. We have previously used the ISA to re-
veal the modular structure of transcriptomes, extracting
Fig. 3 Strain-specificity index (SSI) of the ISO-CTR comparison plotted against that of ATE-CTR. Each dot represents one of the 14537 genes for
which it was possible to assign SSI values (i.e. the genes were not filtered out in at least 12 out of the 18 available strains in both the ISO-CTR
and the ATE-CTR comparisons). The color of the dots reflects the local gene density (the lighter the denser). The SSIs are slightly correlated with
each other (r ≈ 0.007, p ≈ 9.0 × 10−21). The two groups of CE genes, CEISO
ATE (in purple) and group CEISOATE (in green) have relatively low SSIs compared
to the bulk of genes and their SSIs are strongly correlated with each other (CEISO
ATE: r ≈ 0.76, p ≈ 0.01; CEISOATE: r ≈ 0.51, p ≈ 0.13). Thus, the expression
of genes playing a key role at the transcriptional level appear to be less influenced by the strain (lower SSI than the bulk genes) and the treatment
(CE genes fall closer to the diagonal than bulk genes) with respect to the other genes
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robust modular signals [47–52]. One of the advantages
of the ISA is that the search for modules can be biased
towards modules with a particular signature (i.e. a prese-
lected set of “seed” samples, see [52]).
We applied the ISA to the entire set of the 160 RNA-
seq profiles using random selections of strains to define
the seed scores such that all selected strains were
assigned a positive score for ISO and a negative score
for ATE, or vice-versa. CTR samples were not included
as seeds, but we observed that the ISA often added those
samples in the final modules, usually with scores of the
same sign as ATE. After filtering out the highly similar
ones, the ISA revealed 98 transcription modules involv-
ing various subsets of genes that are CE in some but not
all of the strains. Our attempt to annotate these modules
using standard gene enrichment analysis for GO cat-
egories and KEGG pathways revealed a number of highly
significant but rather general terms: “immune response”
(p ≈ 1.5 × 10−12) for Biological Process (BP); “protein-
aceous extracellular matrix” (p ≈ 9.0 × 10−4) for Cellular
Component (CC), and “tetrapyrrole binding” (p ≈ 3.8 ×
10−5) for Molecular Function (MF). Amongst the KEGG
pathways, “PPAR signaling pathway” (p ≈ 5.5 × 10−4) re-
ceived the smallest p-value (see Additional file 2: Table
S3 for all significant GO/KEGG terms). The complete
annotation of the 98 modules in terms of genes, strains
and GO or KEGG terms is available in HTML format as
part of our Additional file 4. This compendium of mod-
ules provides a rich resource of co-expression, allowing
researchers to investigate their strain or gene of interest
and study which other genes or strains responded simi-
larly to the drugs.
We next asked whether module gene expression (i.e.
the average expression of all genes associated with a
module) is correlated with any of the organismal traits
that had previously been measured in these mice [17]
(Additional file 2: Table S4). Figure 4 shows that in-
deed on average module-trait correlations tend to be
significantly larger than those of randomized controls
(Additional file 1: Figure S26 and Methods). Import-
antly, different modules correlate with different traits,
indicating that there might be specific aspects of the
transcriptional program that mediate the different or-
ganismal responses (Additional file 2: Tables S5-S8).
As the standard enrichment analysis did not reveal
very specific terms we sought to further scrutinize a sub-
set of modules with strong (anti-) correlation to any of
the phenotypic traits by applying the scanning approach
we already used to recover more specific GO terms in
relation with the CE genes analysis. Specifically, we pro-
gressively excluded genes with low gene scores from the
evaluation of the GO term significance (see Methods).
The full list of the GO categories enriched in the core
genes of the modules showing highest (anti-) correlation
with the phenotypic traits is provided in the supplement.
A comprehensive analysis of these results is a major task
and we hope that making our transcription modules
available to the community will shed new light on genes
whose differential expression is in concert with known
genes. Here we focus on the results related to heart rate
(HR), which was found to be the trait with the strongest
(anti-) correlation to a transcriptional module. Additional
file 1: Figures S27-S30 summarize the GO analysis per-
formed on the 73 genes of module 38, which was strongly
anti-correlated to HR measured by tail-cuff (TC), whereas
Additional file 1: Figures S31-S34 show the GO analysis
performed on the 211 genes of module 56, whose average
expression was strongly correlated to HR measured by
electrocardiography (ECG).
Module 38 was the most anti-correlated to HR, yet
its ISO samples had predominantly negative scores.
Conversely module 56 was correlated to HR, but its
ISO samples had positive scores. Thus, in fact the genes
of both modules were induced by ISO treatment. In-
spection of the core genes of module 38 (Additional file
1: Figures S27-S30) revealed, at the BP level, a very sig-
nificant enrichment with “Golgi-apparatus” related GO
terms, both regarding the number of inherent terms
and their significance. Among the significant terms, al-
beit only for a specific gene threshold, is also “muscle
system process”. At the CC level we found 8 out of 19
terms related to the rather unspecific term “organelle”.
At the MF level, the highest significance and stability is
reached by the term “kinase activity”. The KEGG terms
most enriched in this module are dominated by the
“fatty acid elongation”. The 211 genes of module 56 are
significantly enriched in the BP GO terms “fibroblast”
and “cytokine activity”, as well as “fibril/extracellular
fibril organization” (Additional file 1: Figure S31).
Among the CC terms associated to this module “mito-
chondrial/respiratory chain” and “fibril components”
are among the most significant (Additional file 1: Fig-
ure S32). The most significant MF terms are dominated
by “transmembrane” (Additional file 1: Figure S33),
whereas at the level of KEGG pathways “TGF-beta
signaling”, “vascular smooth muscle contraction” and
“vasopressin-regulated reabsorption” are among the
most strongly enriched pathways associated to the HR
TC (Additional file 1: Figure S34). This suggests that this
module might be linked to fibrosis, a well-described
process that may occur as a result of sustained (ISO-in-
duced) cardiac stimulation.
Our modular analysis generated a compendium of
transcriptional modules that differ with respect to their
gene and/or strain and/or treatment sets. Yet, distinct
gene sets may still share the same functional annotation,
so we asked to what extent similarity in gene content
goes along similarity in annotation. We used the Jaccard
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indices SGij and S
A
ij to quantify the relative overlap in
genes and annotation terms for any pair of modules
(i, j), respectively (Methods). Plotting one against the
other (Additional file 1: Figure S35) revealed that
these quantities are not very strongly correlated. In
particular, some pairs of modules may overlap only
mildly with respect to genes (say SGij < 0.3), but have a
sizable functional overlap (SAij > 0.5).
In order to further reduce functional complexity and
identify the major functional classes of our modules
we clustered them according to SAij (Additional file 1:
Figures S36-S39). This clustering revealed that the
modules segregate into several blocks of functionally
highly similar profiles, while the blocks are essentially
functionally disjoint. We concentrated on blocks which
contain at least 5 modules with high functional coherence,
referred as to “macro-modules” in the following. For each
of these macro-modules we selected one module (the one
with the highest global annotation significance and broad-
est gene score range) as the representative module of the
functional block (Additional file 2: Table S9). Here we
highlight three representative modules which had strong
enrichment in any of the annotation categories. The three
macro-modules were analyzed at the level of BP, CC, MF
and KEGG pathways and, for each of these categories,
they can be listed (according to the prominently signifi-
cant categories) as: “fibroblast”, “antigen” and “cardiac”
macro-modules for BP (Additional file 1: Figures S40-
S42); “cytoskeleton”, “MHC-complex” and “organelle” for
(Additional file 1: Figures S43-S45); “ribonuclease”,
“hormone” and “pyrimidine” for MF (Additional file 1:
Figures S46-S48). Concerning the KEGG pathways, there
Fig. 4 Module-trait correlations are larger than those of randomized controls. a Bi-clustered module-phenotype correlation matrix for the real data
and (b) reshuffled data. The color code and distributions for these correlations are shown in (c). The two distributions are significantly different
from each other (F ≈ 0.52, p ≈ 3.3 × 10−51) with heavier tails for the real data (Additional file 1: Figure S26). The phenotypes are described in Additional
file 2: Table S4 [17]
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are only two shared macro-modules, which can be
named as “graft” and “kinase” (Additional file 1: Figures
S49-S51). However, intermediate macro-modules (i.e.
macro-modules with lower similarity among the inner
modules) contain “tRNA”, “sodium-potassium channel”
and “Golgi-apparatus” terms (data not shown). The
complete documentation about the macro-modules is
available as part of the supplement.
Discussion
Treatments with the β-blocker atenolol (ATE) and the
β-agonist isoproterenol (ISO) induce inverse physio-
logical responses, notably heart rate is increased by ISO
but reduced by ATE. In our initial study we also ob-
served that while ISO induced cardiac growth, mice
treated with ATE often had smaller hearts [17]. How
these reciprocal effects are mediated has been poorly
understood so far. Our analysis of RNAseq data from
heart tissue within a broad panel of genetically diverse
mice sheds new light at the transcriptional response in-
duced by these drugs.
First, the treatments altered the expression of many
genes for ISO and to much less extent for ATE (Table 1).
The stronger transcriptional response detected under
ISO reflects what we observed at the physiological level
[17], where ISO elicited a stronger effect than ATE on
many traits. It should be noted that while the effective
drug concentrations cannot be readily compared be-
tween ATE and ISO, ATE was used at a dose close to its
upper limit of solubility (see Methods).
Second, the transcriptional responses upon treatment
with the two drugs are not independent. Remarkably,
for the affected genes, and in particular for those whose
transcript levels changed most consistently, we ob-
served a reciprocal effect: most genes that are signifi-
cantly (FDR < 0.05) induced in mice treated with ATE
are repressed under treatment with ISO, and at the
slightly more stringent FDR of 0.01 we did not observe
a single co-induced or co-repressed gene. This counter-
expression is a remarkable result hinting that some
processes responsible for cardiac health may be oper-
ational at some base level from which they may either
be enhanced or repressed, depending on the sensed
level of stress. The 20 genes for which the counter-
expression was most significant are good candidates for
playing important roles in these processes and should
be studied further. Importantly, the transcriptional re-
sponse of the large majority of the CE genes is much
less strain-specific than that of most genes, indicating
that the processes they are involved in are robustly regu-
lated across strains. However, our modular analysis
showed as well that the ISO treatment exerts strain-
specific cardiac transcriptional signatures and phenotypic
traits. These results are in line with independent
evidence showing that some aspects of cardiac remod-
eling in ISO-induced cardiac dysfunction are strain
dependent [53, 54].
It is difficult to annotate these processes in terms of
known gene categories. Enrichment analysis of the most
significant counter-expressed genes pointed at “calcium
signaling” and “regulation of contractile fiber”, both of
which make sense in the context of drugs affecting the
β-adrenergic system. While this manuscript was in prep-
aration, Rau et al. published an investigation that aimed
at mapping genetic contributions to cardiac pathology
induced by longer and more pronounced ISO stimula-
tion in female individuals of the hybrid mouse diversity
panel (HMDP) [54]. This work studied similar traits as
ours but did not address β-blockade. Interestingly their
analysis of differentially expressed genes, as well as gen-
etic variations, also pointed at genes involved in calcium
signaling as important players for cardiomyopathy. In-
cluding genes with less significantly altered expression
pointed at many, but often rather unspecific categories.
It thus seems that the observed changes in gene expres-
sion reflect not only the primary transcriptional re-
sponse, but very likely many secondary effects. This is
also reflected in our modular analysis which revealed
counter-expressed genes over subsets of strains. One
category that is frequently showing up with high signifi-
cance is “immune response”, which may indicate a gen-
eral stress response in mice treated with ISO. Also the
link to ‘tetrapyrrole binding’ is interesting, since this
molecular process is relevant for hemoglobin expres-
sion which has been linked to ISO treatment [55].
It is beyond the scope of this paper to investigate in
detail the various links generated by our analysis. We
hope that with the availability of the raw expression data
and our module database our work will provide a valu-
able resource for experts follow up on these leads. We
are also aware that the modular links which are specific
to only some species call for further genetic investiga-
tions with the aim to identify what might be common in
these strains that elicit a similar response. For example
our expression data would allow for detecting potential
quantitative trait loci for expression (eQTLs) which
would be natural candidates. These and further integrated
analysis combining the various molecular data and organ-
ismal traits will be the subject of further investigations.
Conclusions
We showed that the inverse physiological responses of
mice treated with the antagonistic drugs atenolol and
isoproterenol are reflected by a reciprocal transcrip-
tional response of many genes expressed in the heart.
Our modular gene expression analysis grouped genes
together which exhibit coherent transcription profiles
across some strains and/or treatments. Our study
Prunotto et al. BMC Genomics  (2016) 17:717 Page 10 of 14
provides new insights into the transcriptional response
of the heart to perturbations of the β-adrenergic sys-
tem, implicating several new genes that had not been
associated to this system previously.
Methods
Mice
Animal procedures have been published earlier [17].
Briefly, atenolol (ATE) and isoproterenol (ISO) were ad-
ministered at 10 mg/kg per day for two weeks through
surgically-implanted osmotic minipumps. In accordance
with reports showing their effectiveness on mouse heart
rate and, at least in some of the strains, normalized heart
weight [17], these doses were set so as to trigger as large
phenotypic changes as possible while keeping adverse
events minimal. More specifically, higher concentrations
of ISO induced a number of fatalities, a trend confirmed
by the recent work of Rau et al., who reported ca 30 %
early death in representatives of 105 inbred mouse
strains treated with 30 mg/kg per day of ISO for 3 weeks
[54]. In contrast, phenotypic changes induced by ATE
below 10 mg/kg per day were hardly detectable when
compared to untreated mice, while testing higher con-
centrations was impractical due to the limited solubility
of ATE in water or any vehicle compatible with physio-
logical conditions and delivery through osmotic mini-
pumps for 2 weeks. At the end of the respective
treatments, mice were euthanized and hearts were rap-
idly excised, rinsed in ice-cold phosphate buffered saline
(PBS) solution and blotted dry. Cardiac atria and ventri-
cles were dissected, frozen separately in liquid nitrogen
and stored at −80 °C. Mouse ID numbers refer to those
described in [17]. Corresponding individual phenotypic
values, in particular heart rate, systolic blood pressure,
electrocardiogaphic measurements and heart weight are
available in dataset “maurer1” of the Mouse Phenome
Database (http://phenome.jax.org/).
RNA purification
Total RNA was purified from the cardiac ventricles of
untreated (CTR), ATE, and ISO mice of 18 inbred
strains (ie A/J, BALB/cByJ, BALB/cJ, C3H/HeJ, C57BL/
6J, C57BLKS/J, C58J, CBA/J, DBA/2 J, FVB/NJ, I/LnJ,
LP/J, NOD/ShiLtJ, NZB/BLNJ, PL/J, SJL/J, SM/J and
SWR/J) following the recommendations of Ambion for
the semi-automated MagMax procedure, then stored at
−80 °C. RNA quality and integrity (RIN > 8.1) were veri-
fied on a Bioanalyzer (Agilent).
RNA sequencing
Library preparation and RNA sequencing were performed
by the Beijing Genomics Institute (BGI, Hong Kong,
China), following Illumina’s protocols for poly(A) selection
and HiSeq2000 paired-end sequencing (2 × 100 bp).
Except for strains BALB/cJ (two CTR samples) and
C57BLKS/J (two ISO samples), we had measurements of
three biological replicates for each combination of strains
and treatments; all data passed quality control. An average
of 20 ± 0.8 millions reads were produced for each sample,
in accordance with standard requirements for minimal
sequencing coverage [56, 57]. The sequencing reads were
mapped to a total of 19293 genes using the NCBI37/mm9
Mus musculus reference genome.
Bioinformatics tools
We used the edgeR Bioconductor software package [20],
version 3.2.4, to assess differential gene expression using
default parameters. edgeR is designed to work with
count data providing the appropriate statistical frame-
work for digital gene expression data. Specifically, it is
based on empirical Bayes estimation and exact tests
founded on the negative binomial distribution. Read
counts were normalized with the trimmed mean of M-
values (TMM) method [19].
Differential expression (DE) and Gene Ontology (GO)
analyses
For each comparison (ISO versus CTR, ATE versus
CTR), we filtered out low-count genes, so defined when
showing less than 5 reads across all study samples.
16209 genes survived filtering for the ISO-CTR com-
parison and 16156 for the ATE-CTR one. For CE and
CoE we always considered as background a total of
15966 genes surviving low-count filtering in both com-
parisons, so there was at least some evidence that these
genes could be transcribed in heart tissue. The GO cat-
egories and KEGG pathways related to different DE
genes thresholds were recovered with GOSeq for an
easier scripting implementation of the scanning proced-
ure over the FDR thresholds. The length of the stability
region (along the DE genes definition in units of
-log10FDR) and the GO significance threshold (in units
of -log10 p-values) were slightly adjusted through the dif-
ferent categories in order to list around 10 top categories
for each group, eventually sorted by the total area. These
adjustments follow the intrinsic variability of the max-
imum value of significance achieved by the different type
of categories in the two groups (e.g. p ≈ 10−6 for Biological
Process and p ≈ 10−4 for KEGG pathways).
Transcriptional modules
The ISA algorithm was run on the (log10) TMM-
normalized data after removing genes with low counts
across the 160 samples (16397 genes). The data were
then z-normalized through the built-in “ISANormalize”
function. The iterations were initiated with 100 random
seeds for each threshold combination (8 different gene
thresholds ranging from 0 to 4 and and 8 different
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samples thresholds ranging from 0 to 1 were tested). For
each seed a random selection of strains was chosen with
a 50 % chance for each strain to be part of the seed. The
seed vector was then formed by assigning “1” to ISO
samples, “-1” to ATE samples (or vice-versa) and “0” to
CTR samples. Using more seeds (160, 250, and 1000)
did not result in additional modules, indicating that
module identification had been saturated. The direction
of the iteration (within the “ISAIterate” function) was set
to “updown” for the conditions (samples) and to “up” for
the features (genes). The resulting modules were filtered
out in case of redundancy (with the “ISAUnique” func-
tion) and in case of low robustness (with the “ISAFilter-
Robust” function, carried out with 100 permutations).
The modules were finally selected if they contained both
ATE and ISO samples.
GO analysis of the modules and macro-modules
definition
The correlations between the module condition scores
and 22 organismal phenotypes profiles among each of
the 160 samples were explored after averaging the
phenotypic values over each set of biological replicates.
For the 98 modules obtained with the ISA algorithm
we performed a GO analysis (KEGG pathways, BP, CC
and MF) by progressively including in the analysis only
the genes with the highest scores, applying a step size of
0.05. The significance patterns of the various GO cat-
egories are represented as heatmaps in Additional file 1:
Figures S27-S34 for two modules (which had strong
(anti-) correlation with HR phenotypes). For the sake of
readability, only the top 40 categories (when present in
such number or greater) are shown. We only retained
categories whose p-value was significant in at least 1 %
of all enrichment tests across different gene-score
cutoffs.
Analyzing the GO categories of the 98 modules we re-
alized that modules with very different gene content fre-
quently shared functional annotations. We therefore
evaluated a simple similarity measure between the mod-
ules based on the number of shared GO categories and
clustered the modules according to these similarity
values (see Additional file 1: Figures S36-S39). Specific-
ally, we adopted the Jaccard coefficient as the measure
of similarity. This coefficient is defined as J = |A∩B|/
|AUB|, where A and B are two intersecting sets. In order
to quantitatively define the macro-modules, we ran again
the ISA algorithm (implemented in R with the “isa”
function) on the similarity matrices (one for each GO
category) and selected the resulting macro-modules if
they contained at least 5 modules for an average macro-
module similarity of 0.4. The Jaccard coefficient (used to
find the macro-modules) was evaluated on the basis of
all module categories surviving a p-value below 0.01 in
at least one score step. For the sake of readability, the
heatmaps in Additional file 1: Figures S40-S51 only show
up to 40 entries.
Additional files
Additional file 1: Supplementary figures. (PDF 12000 kb)
Additional file 2: Supplementary tables. (PDF 3020 kb)
Additional file 3: Supplementary information. (PDF 416 kb)
Additional file 4: Supplementary data. Compressed HTML files of 98
expression modules annotated for genes, strains and GO or KEGG terms
(see Additional file 3 for navigation details). (GZ 11006 kb)
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